Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois, USA.
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois, USA.
World Neurosurg. 2022 Oct;166:e672-e680. doi: 10.1016/j.wneu.2022.07.074. Epub 2022 Aug 4.
To compare patient-reported outcome measures (PROMs) and minimum clinically important difference (MCID) achievement following anterior or transforaminal lumbar interbody fusion for isthmic spondylolisthesis in patients presenting with predominant back pain versus predominant leg pain symptoms.
A single-surgeon database was reviewed for anterior or transforaminal lumbar interbody fusion procedures for isthmic spondylolisthesis. Patient demographics, perioperative characteristics, postoperative complications, and PROMs were collected. Demographic/perioperative characteristics were compared among groups using χ and Student t tests for categorical and continuous variables, respectively. Mean PROM scores were compared using an unpaired Student t test. Postoperative improvement from preoperative baseline within each cohort was assessed with paired-samples t test. MCID achievement rates were compared with χ analysis.
In total, 143 patients were included with 65 patients in the predominant back pain and 78 patients in the predominant leg pain cohort. Preoperative visual analog scale (VAS) leg was noted to be significantly greater in predominant leg pain cohort (P < 0.001). Cohorts demonstrated significant mean postoperative differences for the following PROMs at the following postoperative time points: significant differences were noted between cohorts for rate of achievement of MCID for the following PROMs at the following time points: VAS back at 2 years and VAS leg at 6 weeks/12 weeks/6 months/overall (P < 0.036, all).
Compared with patients presenting for surgery with predominant leg pain symptoms, patients undergoing lumbar fusion at L4-L5 and L5-S1 for isthmic spondylolisthesis with predominant back pain symptoms may demonstrate improved long-term clinical outcomes for reported back pain, leg pain, and disability and reduced postoperative length of stay and narcotic consumption.
比较以腰痛为主诉和以腿痛为主诉的腰椎峡部裂患者行前路或经椎间孔腰椎体间融合术后患者报告结局测量(PROMs)和最小临床重要差异(MCID)的达标情况。
回顾单外科医生数据库中前路或经椎间孔腰椎体间融合术治疗腰椎峡部裂的病例。收集患者人口统计学、围手术期特征、术后并发症和 PROMs。使用 χ 检验和学生 t 检验分别对分类变量和连续变量进行组间比较。采用独立样本学生 t 检验比较平均 PROM 评分。采用配对样本 t 检验评估每个队列术后从术前基线的改善情况。采用 χ 分析比较 MCID 达标率。
共纳入 143 例患者,其中以腰痛为主诉的患者 65 例,以腿痛为主诉的患者 78 例。以腿痛为主诉的患者术前视觉模拟评分(VAS)腿痛显著大于以腰痛为主诉的患者(P < 0.001)。在以下术后时间点,两组的以下 PROM 均有显著的平均术后差异:在以下时间点,两组的以下 PROM 的 MCID 达标率有显著差异:2 年时 VAS 腰痛和 6 周/12 周/6 个月/总体时 VAS 腿痛(P < 0.036,均)。
与以腿痛为主诉接受手术的患者相比,以腰痛为主诉接受 L4-L5 和 L5-S1 腰椎峡部裂融合术的患者可能在腰痛、腿痛和残疾的长期临床结局方面有更好的改善,术后住院时间和阿片类药物的使用减少。